Cultures of human osteoblastic cells from dialysis patients: Influence of bone turnover rate on in vitro secretion of interleukin-6 and osteoblastic cell markers

American Journal of Kidney Diseases

Volumn 37, Issue 1, 2001, Pages 30-37

  Sanchez M Carmen ^a   Bajo, M Auxiliadora ^a   Selgas, Rafael ^a   Mate, Alberto ^a   Sanchez Cabezudo M Jesus ^a   López Barea, Fernando ^a   Esbrit, Pedro ^a   Martinez M Eugenia ^a  

^a HOSPITAL UNIVERSITARIO LA PAZ   (Spain)

Author keywords

Bone turnover; Dialysis; Human osteoblastic cells; Interleukin 6 (IL 6); Osteoblastic markers; Renal oateodystrophy

Indexed keywords

ALKALINE PHOSPHATASE; CELL MARKER; GROWTH FACTOR; INTERLEUKIN 6; OSTEOCALCIN; PARATHYROID HORMONE; PROCOLLAGEN C PROTEINASE;

ADULT; AGED; ARTICLE; BONE TURNOVER; CELL CULTURE; CELL GROWTH; CELL PROLIFERATION; CYTOKINE RELEASE; DIALYSIS; FEMALE; HUMAN; HUMAN CELL; MALE; OSSIFICATION; OSTEOBLAST; PARATHYROID HORMONE BLOOD LEVEL; RENAL OSTEODYSTROPHY;

EID: 0035161947     PISSN: 02726386     EISSN: None     Source Type: Journal    
DOI: 10.1053/ajkd.2001.20574     Document Type: Article

References (45)

1. Bone marrow, cytokines, and bone remodeling
2. New concepts in renal osteodystrophy
3. The modulation of the expression of IL-6 and its receptor in human osteoblasts in vitro
4. PCR phenotyping of cytokines, growth factors and their receptors and bone matrix proteins in human osteoblast-like cell lines
5. Osteoblastic cells are involved in osteoclast formation
6. Osteoblast-like cells in the presence of parathyroid hormone release soluble factor that stimulates osteoclastic bone resorption
7. The role of IL-6 type cytokines and their receptors in bone
8. The pathophysiologic roles of interleukin-6 in human disease
9. Interleukin-6 inhibits bone formation in vitro
10. Adenyl-cyclase and interleukin-6 are downstream effects of parathyroid hormone resulting in stimulation of bone resorption
11. The effect of interleukin-6 and soluble interleukin-6 receptor protein on the bone resorptive activity of human osteoclasts generated in vitro
12. Interleukin-6 enhances hypercalcemia and bone resorption mediated by parathyroid hormone-related protein in vivo
13. Bone resorption and mRNA expression of IL-6 and IL-6 receptor in patients with renal osteodystrophy
14. Interleukin-6 and its soluble receptor regulate the expression of insulin-like growth factor binding protein-5 in osteoblast cultures
15. Interleukin-6 and its soluble receptor cause a marked induction of collagenase 3 expression in rat osteoblast cultures
16. Interleukin-6-type cytokines stimulate mesenchymal progenitor differentiation toward the osteoblastic lineage
17. Relationships between histomorphometric features of bone formation and bone cell characteristics in vitro in renal osteodystrophy
18. Proliferation of bone surface-derived osteoblastic cells and control of bone formation
19. Long-term culture of cells from bone affected by Paget's disease
20. Comparison of in vivo and in vitro models of the response of osteoblasts to hormonal regulation with aging
21. Influence of experimental conditions on osteoblast activity in human primary bone cell cultures
22. Osteoblastic proliferation in bone biopsies from patients with end-stage chronic renal failure
23. Uremic serum has inhibitory effects on the proliferative capacity of normal human-derived osteoblasts in vitro
24. Identification of a low molecular weight inhibitor of osteoblast mitogenesis in uremic plasma
25. Histologic quantitation of aluminum in iliac bone from patients with renal failure
26. Bone histomorphometry: Standardization of nomenclature, symbols and units
27. The spectrum of bone disease in end-stage renal failure: An evolving disorder
28. Osteocalcin and bone morphometric parameters in adults without bone disease
29. 3-induced response of various osteoblastic markers in human osteoblastic cells
30. Influence of skeletal site of origin and donor age on osteoblastic cell growth and differentiation
31. C-Terminal parathyroid hormone-related protein inhibits proliferation and differentiation of human osteoblast-like cells
32. A rapid and sensitive method for the quantification of microgram quantities of protein utilizing the principle of protein-dye binding
33. In vitro synthesis of type I collagen: Quantification of carboxyterminal propeptide of procollagen type I versus tritiated proline incorporation
34. A rapid quantitative assay for measuring alkaline phosphatase activity in osteoblastic cells in vitro
35. In vitro production of cytokines by bone surface-derived osteoblastic cells in normal and osteoporotic postmenopausal women: Relationship with cell proliferation
36. Osteocalcin and deoxyribonucleic acid synthesis in vitro and histomorphometric indices of bone formation in postmenopausal osteoporosis
37. Cellular mechanisms of renal osteodystrophy
38. Accumulation of carboxy-terminal fragments of parathyroid hormone-related protein in renal failure
39. 3, parathyroid hormone and glucocorticoids
40. Production of interleukin-6 in human osteoblasts and human bone marrow stromal cells: Evidence that induction by interleukin-1 and tumor necrosis factor-α is not regulated by ovarian steroids
41. Serum interleukin-6 in renal osteodystrophy: Relationship with serum PTH and bone remodeling markers
42. Parathyroid hormone-related protein (107-139) inhibits bone resorption in vivo
43. Interleukin-11 inhibits bone formation in vitro
44. Parathyroid hormone-related protein (107-139) stimulates interleukin-6 expression in human osteoblastic cells
45. 3 on interleukin- 6 synthesis induced by prostaglandins in osteoblasts